Brent L. Larson, EVP, CFO, Treasurer & Secretary at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), bought 5,000 shares at $1.39 ($7K) on 2013-11-08, disclosed to the SEC on 2013-11-08.
Open-market purchase of $7k NAVB by EVP, CFO, Treasurer & Secretary. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NAVB | SELL | 2015-10-05 | $28K | — | Filing → |
| NAVB | SELL | 2015-09-02 | $24K | — | Filing → |
| NAVB | SELL | 2015-08-05 | $21K | — | Filing → |